Effects of gadoxetic acid on quantitative diffusion-weighted imaging of the liver

Journal of Magnetic Resonance Imaging

Volumn 38, Issue 2, 2013, Pages 365-370

  Colagrande, Stefano ^a   Mazzoni, Lorenzo Nicola ^a   Mazzoni, Elisa ^a   Pradella, Silvia ^a  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

ADC; DWI; gadoxetic acid; Gd EOB DTPA; Primovist; quantitative DWI

Indexed keywords

GADOXETIC ACID;

ADULT; AGED; ARTICLE; BODY REGIONS; CANCER DIAGNOSIS; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; FEMALE; HEPATOGRAPHY; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FOCAL NODULAR HYPERPLASIA; LIVER HEMANGIOMA; LIVER METASTASIS; MALE; NUCLEAR MAGNETIC RESONANCE SCANNER; POST HOC ANALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE DIAGNOSIS; RADIOLOGICAL PARAMETERS; RADIOLOGIST;

ADC; DWI; GADOXETIC ACID; GD-EOB-DTPA; PRIMOVIST; QUANTITATIVE DWI;

ADULT; AGED; AGED, 80 AND OVER; ARTIFACTS; CONTRAST MEDIA; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84882566227     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.23978     Document Type: Article

References (24)

1. Qayyum A,. Diffusion-weighted imaging in the abdomen and pelvis: concepts and applications. Radiographics 2009; 29: 1797-1810.
2. Türkbey B, Aras Ö, Karabulut N, et al. Diffusion-weighted MRI for detecting and monitoring cancer: a review of current applications in body imaging. Diagn Interv Radiol 2012; 18: 46-59.
3. Ichikawa T, Haradome H, Hachiya J, Nitatori T, Araki T,. Characterization of hepatic lesions by perfusion-weighted MR imaging with an echoplanar sequence. AJR Am J Roentgenol 1998; 170: 1029-1034. (Pubitemid 28172893)
4. Taouli B,. Diffusion-weighted MR imaging for liver lesion characterization: a critical look. Radiology 2012; 262: 378-380.
5. Karabulut N, Elmas N,. Contrast agents used in MR imaging of the liver. Diagn Interv Radiol 2006; 12: 22-30. (Pubitemid 43379731)
6. Saito K, Araki Y, Park J, et al. Effect of Gd-EOB-DTPA on T2-weighted and diffusion-weighted images for the diagnosis of hepatocellular carcinoma. J Magn Reson Imaging 2010; 32: 229-234.
7. Ahn SJ, Kim MJ, Hong HS, et al. Distinguishing hemangiomas from malignant solid hepatic lesions: a comparison of heavily T2-weighted images obtained before and after administration of gadoxetic acid. J Magn Reson Imaging 2011; 34: 310-317.
8. Tamada T, Ito K, Yoshida K, et al. T2-weighted magnetic resonance imaging of the liver: evaluation of the effect in signal intensity after Gd-EOB-DTPA enhancement. J Comput Assist Tomogr 2010; 34: 182-186.
9. Colagrande S, Pasquinelli F, Mazzoni LN, Belli G, Virgili G,. MR diffusion weighted imaging of healthy liver parenchyma: repeatability and reproducibility of apparent diffusion coefficient measurement. J Magn Reson Imaging 2010; 31: 912-920.
10. Grazioli L, Bondioni MP, Haradome H, et al. Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis. Radiology 2012; 262: 520-529.
11. Patel J, Sigmund EE, Rusinek H, Oei M, Babb JS, Taouli B,. Diagnosis of cirrhosis with intravoxel incoherent motion diffusion MRI and dynamic contrast-enhanced MRI alone and in combination: preliminary experience. J Magn Reson Imaging 2010; 31: 589-600.
12. Istratov AA, Vyvenko OF,. Exponential analysis in physical phenomena. Rev Sci Instrum 1999; 70: 1233-1257. (Pubitemid 129576178)
13. Callot V, Bennett E, Decking UK, Balaban RS, Wen H,. In vivo study of microcirculation in canine myocardium using the IVIM method. Magn Reson Med 2003; 50: 531-540. (Pubitemid 37082078)
14. Wirestam R, Borg M, Brockstedt S, Lindgren A, Holtas S, Stahlberg F,. Perfusion-related parameters in intravoxel incoherent motion MR imaging compared with CBV and CBF measured by dynamic susceptibility-contrast MR technique. Acta Radiol 2001; 42: 123-128. (Pubitemid 33655033)
15. Chiu FY, Jao JC, Chen CY, et al. Effect of intravenous gadolinium-DTPA on diffusion-weighted magnetic resonance images for evaluation of focal hepatic lesions. J Comput Assist Tomogr 2005; 29: 176-180.
16. Choi JS, Kim MJ, Choi JY, Park MS, Lim JS, Kim KW,. Diffusion-weighted MR imaging of liver on 3.0-Tesla system: effect of intravenous administration of gadoxetic acid disodium. Eur Radiol 2010; 20: 1052-1060.
17. Kinner S, Umutlu L, Blex S, et al. Diffusion weighted MR imaging in patients with HCC and liver cirrhosis after administration of different gadolinium contrast agents: is it still reliable. Eur J Radiol 2012; 81: 625-628.
18. Le Bihan D, Breton E, Lallemand D, Grenier P, Cabanis E, Laval-Jeantet M,. MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology 1986; 161: 401-407. (Pubitemid 17173295)
19. Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, Laval-Jeantet M,. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 1988; 168: 497-505.
20. Pasquinelli F, Belli G, Mazzoni LN, et al. MR-diffusion imaging in assessing chronic liver diseases: does a clinical role exist. Radiol Med 2012; 117: 242-253.
21. Pasquinelli F, Belli G, Mazzoni LN, Grazioli L, Colagrande S,. Magnetic resonance diffusion-weighted imaging: quantitative evaluation of age-related changes in healthy liver parenchyma. Magn Reson Imaging 2011; 29: 805-812.
22. Hamm B, Staks T, Mühler A, et al. Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. Radiology 1995; 195: 785-792.
23. Lee NK, Kim S, Lee JW, Lee SH, Kang DH, Kim GH, Seo HI,. Biliary MR imaging with Gd-EOB-DTPA and its clinical applications. Radiographics 2009; 29: 1707-1724.
24. Schering AG, Global Business Unit Diagnostic Imaging. Primovist product monograph. 1st edition, February 2005, Schering AG, 13342 Berlin, Germany.